Postpartum hypertension (high blood pressure in the first 42 days after delivery) is the leading reason for readmission to the hospital after a delivery stay. Current guidelines recommend starting medicines to lower blood pressure when a woman’s postpartum measurements are 150/100mmHg or higher on at least 2 occasions at least 4 hours apart in the first 4 days following delivery. However, these recommendations are largely based on expert opinion. In this study, researchers asked how well the blood pressure cutoff of 150/100mmHg can predict a patient needing to be readmitted for high blood pressure problems postpartum. The researchers analyzed a dataset of nearly 25,000 women and found that a blood pressure cutoff of measurements 140/90mmHg or higher was the most reliable predictor of postpartum readmissions for high blood pressure problems. Next steps should be to conduct more studies to test these new blood pressure cutoffs and determine if starting blood pressure lowering medicines at lower blood pressures can in fact help postpartum women avoid being readmitted to the hospital.
LINK: https://pubmed.ncbi.nlm.nih.gov/33451628/
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Article Titles: Association of Birth Year of Pregnant Individuals With Trends in Hypertensive Disorders of Pregnancy in the United States, 1995-2019 Trends in Hypertensive Disorders of Pregnancy i...
HMOX1 Genetic Polymorphisms Display Ancestral Diversity and May Be Linked to Hypertensive Disorders in Pregnancy “Racial disparity” means that a condition may happen more often in a speci...
First trimester serum biomarker discovery study for early onset, preterm onset and preeclampsia at term More and more tests are being developed to help predict if somebody will go on to develop preec...
Gut Dysbiosis Promotes Preeclampsia by Regulating Macrophages and Trophoblasts Over the last few decades, research has exploded on the “gut microbiome,” meaning what types of (and how man...
Thanks to everyone who commented and shared on social media about this recent Research Roundup article. Our organization recognizes that talking about certain factors in the cause of preeclampsia, lik...